{"id":"https://openalex.org/W2964067915","doi":"https://doi.org/10.1182/blood.v130.suppl_1.3188.3188","title":"Identification of Cross-Reactive Targets of TCR-Based Therapeutic Agents within the Human Proteome","display_name":"Identification of Cross-Reactive Targets of TCR-Based Therapeutic Agents within the Human Proteome","publication_year":2017,"publication_date":"2017-12-07","ids":{"openalex":"https://openalex.org/W2964067915","doi":"https://doi.org/10.1182/blood.v130.suppl_1.3188.3188","mag":"2964067915"},"language":"en","primary_location":{"id":"mag:2964067915","doi":"https://doi.org/10.1182/blood.v130.suppl_1.3188.3188","is_oa":false,"landing_page_url":"https://ashpublications.org/blood/article/130/Supplement%201/3188/114814/Identification-of-Cross-Reactive-Targets-of-TCR","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029670586","display_name":"Ron S. Gejman","orcid":"https://orcid.org/0000-0001-5138-2772","observed_orcids":["https://orcid.org/0000-0001-5138-2772"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ron S. Gejman","raw_affiliation_strings":[", memorial sloan-kettering cancer center, New York, NY"],"raw_orcid":"https://orcid.org/0000-0001-5138-2772","affiliations":[{"raw_affiliation_string":", memorial sloan-kettering cancer center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062508226","display_name":"Tao Dao","orcid":"https://orcid.org/0000-0001-9937-6283","observed_orcids":["https://orcid.org/0000-0001-9937-6283"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tao Dao","raw_affiliation_strings":[", memorial sloan-kettering cancer center, New York, NY"],"raw_orcid":"https://orcid.org/0000-0001-9937-6283","affiliations":[{"raw_affiliation_string":", memorial sloan-kettering cancer center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006680533","display_name":"David A. Scheinberg","orcid":"https://orcid.org/0000-0002-4160-923X","observed_orcids":["https://orcid.org/0000-0002-4160-923X","https://orcid.org/0009-0009-0651-7389"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Scheinberg","raw_affiliation_strings":[", memorial sloan-kettering cancer center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":", memorial sloan-kettering cancer center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.1213,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.55626073,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"130","issue":null,"first_page":"3188","last_page":"3188"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.45649999380111694,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.45649999380111694,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.18520000576972961,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.1354999989271164,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/peptide-mhc-class-i-complexes","display_name":"peptide-MHC class I complexes","score":0.6629999876022339},{"id":"https://openalex.org/keywords/wt1","display_name":"WT1","score":0.6740000247955322},{"id":"https://openalex.org/keywords/prame","display_name":"PRAME","score":0.9990000128746033},{"id":"https://openalex.org/keywords/t-cell-receptor-engineering","display_name":"T cell receptor engineering","score":0.39500001072883606},{"id":"https://openalex.org/keywords/immtac","display_name":"ImmTAC","score":0.5820000171661377},{"id":"https://openalex.org/keywords/mhc-class-i-antigen-presentation","display_name":"MHC class I antigen presentation","score":0.44600000977516174},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.6380000114440918}],"concepts":[{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.8186691403388977},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.6329010128974915},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6023320555686951},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6019526124000549},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4825655519962311},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.4549538493156433},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.42911627888679504},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.40432414412498474},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28694096207618713},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.17908117175102234}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2964067915","doi":"https://doi.org/10.1182/blood.v130.suppl_1.3188.3188","is_oa":false,"landing_page_url":"https://ashpublications.org/blood/article/130/Supplement%201/3188/114814/Identification-of-Cross-Reactive-Targets-of-TCR","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3011189708","https://openalex.org/W6991213325","https://openalex.org/W3048258342","https://openalex.org/W7202129234","https://openalex.org/W4416448616","https://openalex.org/W2975906941","https://openalex.org/W4389016267","https://openalex.org/W4391969651","https://openalex.org/W4380264494","https://openalex.org/W7068057964"],"abstract_inverted_index":{"Abstract":[0],"TCR-based":[3,79],"therapeutic":[4,257],"cells":[5,36,117,325],"and":[6,16,37,45,63,86,92,129,170,219,308,333,335,346,358,408,429],"agents":[7,33],"(antigen-adapted":[8],"T":[9,13,137,236,328,426,430],"cell":[10,138,427,431],"infusions,":[11],"TCR-engineered":[12],"cells,":[14,237,329],"ImmTACs,":[15],"TCR":[17,169,234,332,345],"mimic":[18,141,433],"antibodies)":[19],"have":[20,46,199,260,349],"emerged":[21],"as":[22],"a":[23,73,189,207,262,287,351,360,436],"new":[24],"class":[25],"of":[26,31,66,78,153,161,168,191,285,344,353,363,374,385,406,425,491,510],"effective":[27],"cancer":[28],"therapeutics.":[29],"Cross-reactivities":[30],"these":[32,67,119,134,256],"to":[34,43,71,115,133,146,187,206,221,250,267,301,331,341,382,421],"off-target":[35,64,242],"tissues":[38],"are":[39,55,99,127],"poorly":[40],"understood,":[41],"difficult":[42],"predict,":[44],"resulted":[47],"in":[48,96,103,110,150,338,378,389,435],"serious,":[49],"sometimes":[50],"fatal":[51],"adverse":[52],"reactions.":[53],"There":[54],"no":[56,130],"reliable":[57],"techniques":[58],"for":[59,75,255,319],"determining":[60],"the":[61,151,159,211,222,233,302,370,390,397,423],"on-target":[62],"reactivity":[65],"agents.":[68],"We":[69,198,348],"sought":[70],"develop":[72],"method":[74,264],"predicting":[76],"reactivities":[77],"agents,":[80],"starting":[81],"with":[82,107,241,396],"three":[83],"well-defined":[84],"tools":[85],"systems.":[87],"Wilms":[88,212],"Tumor":[89,213],"1":[90,214],"(WT1)":[91],"Preferentially":[93,223],"expressed":[94],"antigen":[95],"melanoma":[97],"(PRAME)":[98],"overexpressed":[100],"protein-coding":[101],"genes":[102,120],"many":[104],"hematologic":[105],"malignancies":[106],"restricted":[108],"expression":[109],"normal":[111],"tissue.":[112],"The":[113,163,372,400],"ability":[114],"target":[116,273],"expressing":[118,286,324],"is":[121,276,298],"limited":[122],"because":[123],"their":[124],"protein":[125,215],"products":[126],"intracellular":[128,179],"small":[131],"molecules":[132],"drugs":[135],"exist.":[136],"receptor":[139,432],"(TCR)":[140],"antibodies":[142,195,434],"(TCRm)":[143],"can":[144,172,239,326,366],"bind":[145,330],"8-11aa":[147],"peptide":[148,164,209,290,314,317],"antigens":[149],"context":[152],"major":[154],"histocompatibility":[155],"complexes":[156],"(MHC)":[157],"on":[158,235,271,321,487,506],"surface":[160],"cells.":[162,274],"MHC":[165],"(pMHC)":[166],"targets":[167],"TCRm":[171,185,202,238,334],"be":[173,336,367,419],"derived":[174],"from":[175,210],"wild-type":[176],"or":[177,180,316,493,512],"mutated,":[178],"extracellular":[181],"proteins,":[182],"thereby":[183],"allowing":[184],"therapeutics":[186],"access":[188],"universe":[190],"proteins":[192],"that":[193,244,365,393,410],"traditional":[194],"cannot":[196],"reach.":[197],"generated":[200],"two":[201],"antibodies,":[203],"one":[204,220],"directed":[205],"HLA-A*02:01":[208,356],"(WT1":[216],"126-134:":[217],"RMFPNAPYL)":[218],"Expressed":[224],"Antigen":[225],"In":[226,248],"Melanoma":[227],"(PRAME":[228],"300-309:":[229],"ALYVDSLFFL)":[230],"protein.":[231],"Like":[232],"cross-react":[240],"peptides":[243,254],"share":[245],"sequence":[246,307],"homology.":[247],"order":[249],"identify":[251],"endogenous":[252],"cross-reactive":[253,395],"drugs,":[258],"we":[259],"created":[261],"minigene-based":[263],"(termed":[265],"\u201cPresentER\u201d)":[266],"genetically":[268],"encode":[269],"pMHC":[270,364],"model":[272],"PresentER":[275,323,375,401,417],"an":[277,488,507],"easily":[278],"clonable,":[279],"Illumina-sequencing":[280],"compatible":[281],"genetic":[282],"system":[283,297],"capable":[284],"single":[288],"MHC-I":[289,386,404],"ligand":[291],"(8-12":[292],"amino":[293,305],"acid":[294,306],"long).":[295],"This":[296],"highly":[299],"specific":[300],"encoded":[303,388],"linear":[304],"does":[309],"not":[310,412],"require":[311],"proteasome":[312],"cleavage,":[313],"transport":[315],"processing":[318],"presentation":[320],"MHC-I.":[322],"stimulate":[327],"used":[337,420],"pooled":[339,361],"screens":[340],"discover":[342,422],"ligands":[343,357,387,405],"TCRm.":[347,371,399],"cloned":[350],"library":[352],"~12,000":[354],"exomic":[355],"performed":[359],"screen":[362,402],"recognized":[368],"by":[369,414],"utility":[373],"was":[376],"validated":[377],"its":[379],"first":[380],"application":[381],"find":[383],"dozens":[384],"human":[391],"proteome":[392],"were":[394,411],"ESK1":[398,407],"revealed":[403],"Pr20":[409],"predictable":[413],"other":[415],"methods.":[416],"may":[418],"ligandome":[424],"receptors":[428],"native,":[437],"cell-based":[438],"context.":[439],"Disclosures":[443],"Gejman:":[445],"Memorial":[446,457,468],"Sloan":[447,458,469],"Kettering":[448,459,470],"Cancer":[449,460,471],"Center:":[450,461,472],"Patents":[451,462,473,496],"&":[452,463,474,497],"Royalties:":[453,464,475],"US":[454,478],"62/62/395,577.":[455],"Dao:":[456],"WO2012135854":[465,476],"A2.":[466],"Scheinberg:":[467],"A2,":[477],"Provisional":[479],"62/62/395,577;":[480],"Actinium":[481],"Pharmaceuticals:":[482],"Consultancy,":[483,501],"Equity":[484,502],"Ownership,":[485,503],"Membership":[486,505],"entity's":[489,508],"Board":[490,509],"Directors":[492,511],"advisory":[494,513],"committees,":[495],"Royalties;":[498],"Eureka":[499],"Therapeutics:":[500],"Honoraria,":[504],"committees.":[514]},"counts_by_year":[{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2019-07-30T00:00:00"}